Apr 16 |
Genmab Acquires A Missing Piece For Its Pipeline
|
Apr 16 |
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
|
Apr 15 |
Roche reports survival data for new dual-acting lymphoma drug
|
Apr 15 |
Transactions in Connection with Share Buy-back Program Genmab
|
Apr 3 |
Genmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover
|
Apr 3 |
Stocks to Watch Wednesday: Disney, Intel, Tesla, Trump Media
|
Apr 3 |
Genmab buys ProfoundBio for $1.8B, adding to ADC dealmaking flurry
|
Apr 3 |
Genmab Strengthens Oncology Portfolio With $1.8 Bln Acquisition of ProfoundBio
|
Apr 3 |
Genmab to purchase US-based biotech company ProfoundBio for $1.8 billion in all-cash deal
|
Apr 3 |
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
|